United States - English - NLM (National Library of Medicine)

paxvax, inc. - vibrio cholerae cvd 103-hgr strain live antigen (unii: v9g528e9e0) (vibrio cholerae cvd 103-hgr strain live antigen - unii:v9g528e9e0) - vibrio cholerae cvd 103-hgr strain live antigen 1200000000 [cfu] - vaxchora is a vaccine indicated for active immunization against disease caused by vibrio cholerae serogroup o1 in adults 18 through 64 years of age traveling to cholera-affected areas. the effectiveness of vaxchora has not been established in persons living in cholera-affected areas. the effectiveness of vaxchora has not been established in persons who have pre-existing immunity due to previous exposure to v. cholerae or receipt of a cholera vaccine. vaxchora has not been shown to protect against disease caused by v. cholerae serogroup o139 or other non-o1 serogroups. do not use in persons who have a history of severe allergic reaction (e.g., anaphylaxis) to any ingredient of vaxchora or to a previous dose of any cholera vaccine [see description (11)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to vaxchora during pregnancy. to enroll in or obtain information about the registry, please call paxvax at 1-800-533-5899. risk summary vaxch

Singapore - English - HSA (Health Sciences Authority)

aenon pharmaceuticals sea pte. ltd. - recombinant cholera toxin b subunit (rctb); vibrio cholerae o1 inaba classic strain (heat inactivated); vibrio cholerae o1 inaba el tor strain (formalin inactivated); vibrio cholerae o1 ogawa classic strain (formalin inactivated); vibrio cholerae o1 ogawa classic strain (heat inactivated) - suspension - 1 mg/dose - recombinant cholera toxin b subunit (rctb) 1 mg/dose; vibrio cholerae o1 inaba classic strain (heat inactivated) 31.25 x 10^9 bacteria; vibrio cholerae o1 inaba el tor strain (formalin inactivated) 31.25 x 10^9 bacteria; vibrio cholerae o1 ogawa classic strain (formalin inactivated) 31.25 x 10^9 bacteria; vibrio cholerae o1 ogawa classic strain (heat inactivated) 31.25 x 10^9 bacteria

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valneva uk ltd - vibrio cholerae - oral suspension

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - v.cholerae inaba 48 classical biotype,; v.cholerae inaba 6973 el tor biotype,; v.cholerae ogawa 50 classical biotype,; v.cholerae ogawa 50 classical biotype,; vibrio cholerae 0139, strain 4260 b, inactivated -

Singapore - English - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - vedolizumab - injection, powder, for solution - vedolizumab 300 mg/vial

New Zealand - English - Medsafe (Medicines Safety Authority)

takeda new zealand limited - vedolizumab 300mg;  ;   - powder for injection - 300 mg - active: vedolizumab 300mg     excipient: arginine hydrochloride histidine histidine hydrochloride monohydrate polysorbate 80 sucrose - treatment of adult patients with moderate to severe ulcerative colitis who have had an inadequate response with, lost response to, or are intolerant to either conventional therapy or a tumour necrosis factor-alpha (tnf alpha) antagonist.

Ireland - English - HPRA (Health Products Regulatory Authority)

wellcome (ireland) limited - cholera vaccine - 10 millilitre

Ireland - English - HPRA (Health Products Regulatory Authority)

wellcome (ireland) limited - cholera vaccine - 25 millilitre

Ireland - English - HPRA (Health Products Regulatory Authority)

ucb pharma limited - cholera vaccine -

India - English - Central Drugs Standard Control Organization

haffkine - cholera vaccine - vaccine - 30ml v.